Trinity Biotech plc (NASDAQ:TRIB – Get Free Report) saw a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 18,400 shares, an increase of 70.4% from the June 30th total of 10,800 shares. Based on an average daily trading volume, of 52,400 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.3% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
Separately, StockNews.com assumed coverage on Trinity Biotech in a report on Sunday, July 21st. They issued a “buy” rating on the stock.
Check Out Our Latest Stock Report on TRIB
Trinity Biotech Trading Down 3.7 %
Trinity Biotech (NASDAQ:TRIB – Get Free Report) last announced its quarterly earnings results on Thursday, May 23rd. The company reported ($0.37) earnings per share for the quarter. The company had revenue of $14.70 million during the quarter. As a group, research analysts expect that Trinity Biotech will post -2.17 EPS for the current year.
About Trinity Biotech
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Featured Articles
- Five stocks we like better than Trinity Biotech
- How to Invest in Small Cap Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Most Volatile Stocks, What Investors Need to Know
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Market Cap Calculator: How to Calculate Market Cap
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Trinity Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Biotech and related companies with MarketBeat.com's FREE daily email newsletter.